260 related articles for article (PubMed ID: 28800289)
1. Fate-Regulating Circuits in Viruses: From Discovery to New Therapy Targets.
Pai A; Weinberger LS
Annu Rev Virol; 2017 Sep; 4(1):469-490. PubMed ID: 28800289
[TBL] [Abstract][Full Text] [Related]
2. Probabilistic control of HIV latency and transactivation by the Tat gene circuit.
Cao Y; Lei X; Ribeiro RM; Perelson AS; Liang J
Proc Natl Acad Sci U S A; 2018 Dec; 115(49):12453-12458. PubMed ID: 30455316
[TBL] [Abstract][Full Text] [Related]
3. Mapping the architecture of the HIV-1 Tat circuit: A decision-making circuit that lacks bistability and exploits stochastic noise.
Razooky BS; Weinberger LS
Methods; 2011 Jan; 53(1):68-77. PubMed ID: 21167940
[TBL] [Abstract][Full Text] [Related]
4. Nonlatching positive feedback enables robust bimodality by decoupling expression noise from the mean.
Razooky BS; Cao Y; Hansen MMK; Perelson AS; Simpson ML; Weinberger LS
PLoS Biol; 2017 Oct; 15(10):e2000841. PubMed ID: 29045398
[TBL] [Abstract][Full Text] [Related]
5. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.
Chakraborty S; Kabi M; Ranga U
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338
[TBL] [Abstract][Full Text] [Related]
6. Taking out Tat.
Jones KA
Nat Biotechnol; 1996 Nov; 14(11):1542-3. PubMed ID: 9634816
[No Abstract] [Full Text] [Related]
7. Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription.
Mousseau G; Aneja R; Clementz MA; Mediouni S; Lima NS; Haregot A; Kessing CF; Jablonski JA; Thenin-Houssier S; Nagarsheth N; Trautmann L; Valente ST
mBio; 2019 Jul; 10(4):. PubMed ID: 31266880
[TBL] [Abstract][Full Text] [Related]
8. HIV latency reversing agents act through Tat post translational modifications.
Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
[TBL] [Abstract][Full Text] [Related]
9. The Molecular Basis for Human Immunodeficiency Virus Latency.
Mbonye U; Karn J
Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
[TBL] [Abstract][Full Text] [Related]
10. Transient Thresholding: A Mechanism Enabling Noncooperative Transcriptional Circuitry to Form a Switch.
Aull KH; Tanner EJ; Thomson M; Weinberger LS
Biophys J; 2017 Jun; 112(11):2428-2438. PubMed ID: 28591615
[TBL] [Abstract][Full Text] [Related]
11. Transient-mediated fate determination in a transcriptional circuit of HIV.
Weinberger LS; Dar RD; Simpson ML
Nat Genet; 2008 Apr; 40(4):466-70. PubMed ID: 18344999
[TBL] [Abstract][Full Text] [Related]
12. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional control of HIV replication by multiple modulators and their implication for a novel antiviral therapy.
Victoriano AF; Okamoto T
AIDS Res Hum Retroviruses; 2012 Feb; 28(2):125-38. PubMed ID: 22077140
[TBL] [Abstract][Full Text] [Related]
14. Distinct promoter activation mechanisms modulate noise-driven HIV gene expression.
Chavali AK; Wong VC; Miller-Jensen K
Sci Rep; 2015 Dec; 5():17661. PubMed ID: 26666681
[TBL] [Abstract][Full Text] [Related]
15. Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure.
Jin H; Li D; Lin MH; Li L; Harrich D
Viruses; 2020 Apr; 12(4):. PubMed ID: 32276443
[TBL] [Abstract][Full Text] [Related]
16. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
Quivy V; De Walque S; Van Lint C
Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
[TBL] [Abstract][Full Text] [Related]
17. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
[TBL] [Abstract][Full Text] [Related]
18. 6-desfluoroquinolones as HIV-1 Tat-mediated transcription inhibitors.
Tabarrini O; Massari S; Cecchetti V
Future Med Chem; 2010 Jul; 2(7):1161-80. PubMed ID: 21426162
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 positive feedback and lytic fate.
Nachman I; Ramanathan S
Nat Genet; 2008 Apr; 40(4):382-3. PubMed ID: 18368125
[No Abstract] [Full Text] [Related]
20. The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies.
Rice AP
Curr Pharm Des; 2017; 23(28):4098-4102. PubMed ID: 28677507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
